Breakthrough Prize in Life Sciences

The Breakthrough Prize in Life Sciences is an award Since 2013 award for research achievements in Biological and Medical Sciences (Life Sciences ). Every year there are six winners, who also belong to the selection committee for future winners. In the first year eleven winners were appointed.

The prize is endowed with three million dollars for each award winner. It was founded by Mark Zuckerberg and Priscilla Chan Facebook, Sergey Brin of Google, Yuri Milner (who is also the founder of the similarly highly doped Fundamental Physics Prize ), and Anne Wojcicki (founder of 23andMe ). Chairman of the Foundation is Arthur D. Levinson of Genentech and Apple.

Award winners

  • 2013: Cornelia Bargmann of Genetics of neural circuits and behavior and the discovery of a lead molecule in the development of the nervous system
  • David Botstein, for linkage mapping of hereditary diseases in humans with DNA polymorphisms
  • Lewis C. Cantley, for the discovery of the PI 3- kinase and its role in cancer metabolism
  • Hans Clevers, for the elucidation of the Wnt signaling pathway in stem cells and cancer
  • Napoleone Ferrara, which led to treatments for cancer and eye diseases for discoveries in angiogenesis
  • Eric S. Lander, for the discovery of general principles to the discovery of genes for human diseases
  • Titia de Lange, for research on telomeres, the Enlightenment as they protect chromosome ends and their role in genome instability in cancer
  • Charles L. Sawyers, for cancer genes and it tailored therapies
  • Bert Vogelstein, genetics of cancer and tumor suppressor genes
  • Robert A. Weinberg, for characterization of human cancer genes
  • Shinya Yamanaka, for induced pluripotent stem cells
  • James P. Allison, for the discovery of the blockade of T -cell control as a cancer therapy
  • Mahlon DeLong, for the description of the faulty circuits in Parkinson's disease and thus the creation of the foundations of deep brain stimulation
  • Michael N. Hall, for the discovery of protein kinase TOR ( target of rapamycin, mTOR in mammals ) and its role in the regulation of cell growth
  • Have Robert Langer, for his discoveries that led to the development of new biomaterials and systems for targeted drug delivery
  • Richard Lifton, are for the discovery of genes and biochemical mechanisms of arterial hypertension based
  • Alexander Varshavsky, for the discovery of the defining molecular and biological factors of the intracellular protein degradation
Charles Sawyers Oncogene Robert Weinberg Parkinson's disease Robert S. Langer Richard P. Lifton
143852
de